As epilepsy is commonly associated with mitochondrial disease, targeting GPX4 to stimulate the enzymatic removal of lipid hydroperoxides could present a potential interventional strategy for mitochondrial disease-associated epilepsy, such as pontocerebellar hypoplasia type 6 [52]. This evidence concerns the gene GPX4 and epilepsy.